TNFSF10 and cancer: TRAIL has long been perceived as a potential attractive chemotherapeutic agent, since it can kill cancer cells without conferring significant toxicity to normal cells [21], however, to date, no TRAIL-based therapy has demonstrated both potency and lack of systemic toxicity in any clinical trial [17, 22, 23].